Paper Details

  1. Home
  2. Paper Details

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.

Author: DieterichDouglas T, HanSteven-Huy B, JacobsonIra M, KeeffeEmmet B, MartinPaul, SchiffEugene R, TobiasHillel, WrightTeresa L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Chronic hepatitis B (CHB) is a serious public health issue, with 25% of those infected as newborns dying prematurely from liver complications. This updated treatment guideline for CHB, based on scientific evidence, emphasizes the importance of monitoring viral levels and achieving the lowest possible levels with antiviral medications. Treatment is recommended for patients with high viral levels, with different thresholds based on the type of infection and liver health. Several antiviral drugs are approved, each with advantages and disadvantages, including effectiveness, safety, potential for resistance, ease of use, and cost.
Paper Details　
Original Abstract of the Article :
Chronic hepatitis B (CHB) is an important public health problem worldwide and in the United States, with approximately 25% of patients infected as neonates dying prematurely from cirrhosis or liver cancer. A treatment algorithm for CHB previously developed and published by a panel of United States h...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.cgh.2006.05.016

データ提供：米国国立医学図書館（NLM）

Chronic Hepatitis B: A Long and Challenging Journey Through the Desert of Liver Disease

The world of liver disease is like a vast and unforgiving desert, my friends. This study, my dear readers, is like a group of researchers setting out on a new expedition to find effective treatments for chronic hepatitis B (CHB), a long-term infection that can lead to serious health complications. The researchers are presenting an updated treatment algorithm for CHB, taking into account the latest scientific advancements and the availability of new medications.

A New Compass for Chronic Hepatitis B: An Updated Treatment Algorithm

This research is like a caravan equipped with a new and improved compass, navigating towards more effective treatment options for CHB. The researchers have created an updated treatment algorithm that incorporates the latest scientific discoveries and therapeutic approaches, providing clinicians with a comprehensive guide for managing this challenging condition.

A New Path Through the Desert of Liver Disease: A Guide for Chronic Hepatitis B Treatment

As a camel, I understand the importance of having a reliable guide when navigating through a challenging landscape. This research is like a group of scientists providing a much-needed map for clinicians who are treating patients with chronic hepatitis B. The updated treatment algorithm offers valuable insights into the latest therapeutic options and management strategies.

Dr. Camel's Conclusion

This research is a vital step in the fight against chronic hepatitis B. The updated treatment algorithm provides clinicians with a comprehensive guide for managing this challenging condition, potentially leading to improved outcomes for patients and a greater understanding of this complex disease.

Date :
  1. Date Completed 2006-11-09
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16844425

DOI: Digital Object Identifier

10.1016/j.cgh.2006.05.016

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.